Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Mallinckrodt
Harvard Business School
Express Scripts
AstraZeneca

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

Claims for Patent: 6,242,495

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,242,495
Title: Compounds and compositions for delivering active agents
Abstract:Carrier compounds and compositions therewith which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
Inventor(s): Leone-Bay; Andrea (Ridgefield, CT), Wang; Eric Yanjun (Perry Hall, MD), Sarubbi; Donald J. (Carmel, NY), Leipold; Harry (Elmsford, NY), Wang; Nai Fang (Long Island City, NY)
Assignee: Emisphere Technologies, Inc. (Tarrytown, NY)
Application Number:09/596,016
Patent Claims:1. A method for administering parathyroid hormone to an animal in need of parathyroid hormone, the method comprising administering orally to the animal a compound having the formula ##STR41##

or a salt thereof, in combination with parathyroid hormone.

2. The method of claim 1, comprising administering the salt of the compound.

3. The method of claim 2, wherein the salt is a sodium salt.

4. A composition comprising:

(a) parathyroid hormone; and

(b) a compound having the formula ##STR42##

or a salt thereof.

5. The composition of claim 4, comprising the salt of the compound.

6. The method of claim 5, wherein the salt is a sodium salt.

7. A compound having the formula ##STR43##

or a salt thereof.

8. A method for preparing a composition, said method comprising mixing:

(A) at least one active agent;

(B) at least one compound as defined in claim 7; and

(C) optionally, a dosing vehicle.

9. The method of claim 8, wherein the active agent is parathyroid hormone.

10. The method of claim 9, wherein component (B) is a salt.

11. The method of claim 10, wherein the salt is a sodium salt.

Details for Patent 6,242,495

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial Emisphere Technologies, Inc. (Tarrytown, NY) 2036-04-30 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial Emisphere Technologies, Inc. (Tarrytown, NY) 2036-04-30 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial Emisphere Technologies, Inc. (Tarrytown, NY) 2036-04-30 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial Emisphere Technologies, Inc. (Tarrytown, NY) 2036-04-30 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Harvard Business School
Merck
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.